Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets

Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets The approval by the US Food Drug Administration (USFDA) for the abbreviated new drug application (ANDA) Rivaroxaban tablet is for multiple strengths of 10 mg, 15 mg, and 20 mg, Alembic Pharmaceuticals said in a regulatory filing.

No comments:

Post a Comment